Characterization of an enhancer required for 1,25-dihydroxyvitamin D3- dependent transactivation of the rat osteocalcin gene

Journal of Cellular Biochemistry

Volumn 73, Issue 3, 1999, Pages 400-407

  Sneddon, W Bruce ^a   Demay, Marie B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Rat osteocalcin gene; VDRE

Indexed keywords

CALCITRIOL; OSTEOCALCIN; VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DNA FLANKING REGION; ENHANCER REGION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN INTERACTION; RAT; TRANSACTIVATION; VIRUS GENE;

ANIMALS; CALCITRIOL; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENHANCER ELEMENTS (GENETICS); MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDE PROBES; OSTEOCALCIN; RATS; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0033562532     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990601)73:3<400::AID-JCB11>3.0.CO;2-O     Document Type: Article

References (27)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1992. Current protocols in molecular biology. New York, NY: Greene Publishing Associates and Wiley-Interscience.
2. Bannister AJ, Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 84:641-643.
3. Cavailles V, Dauvois S, Danielian PS, Parker MG. 1994. Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013.
4. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751.
5. 3 on gene transcription. J Biol Chem 264:2279-2282.
6. 3. Proc Natl Acad Sci USA87:369-373.
7. 3. Proc Natl Acad Sci USA 89: 8097-8101.
8. 3 receptor interactions with target sequences in the rat osteocalcin gene. Mol Endocr 6:557-062.
9. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M. 1994. Estrogen receptor-associated proteins-possible mediators of hormone-induced transcription. Science 264:1455-1458.
10. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG. 1996. ACBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
11. Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
12. LeDouarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Lesson R. 1995. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033.
13. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD. 1995. Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature 374:91-94.
14. Maurer RA, Notides AC. 1987. Identification of an estrogen-responsive element from the 5′ flanking region of the rat prolactin gene. Mol Cell Biol 7:4247-4254.
15. Morrison NA, Shine J, Fragonas J-C, Verkest V, McMenemy ML, Eisman JA. 1989. 1,25-Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246:1158-1161.
16. Nye JA, Petersen J, Gunther CV, Jonsen MD, Graves BJ. 1992. Interaction of murine Ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev 6:975-990.
17. O'Brien RM, Noisin EL, Suwanichkul A, Yamasaki T, Lucas PC, Wang J, Powell DR, Granner DK. 1995. Hepatic nuclear factor 3- and hormone-regulated expression of the phosphenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol 15:1747-1758.
18. Ogryzko W, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
19. 3 24-hydroxylase gene. J Biol Chem 271: 30381-30385.
20. Oñate SA, Tsai SY, Tsai M-J, O'Malley BW. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
21. Prost E, Moore DD. 1986. CAT vectors for the analysis of eukaryotic promoters and enhancers. Gene 45:107-111.
22. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467.
23. Sneddon WB, Bogado CE, Kiernan MS, Demay MB. 1997a. DNA sequences downstram from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation. Mol Endocrin 11:210-217.
24. Sneddon WB, Demay MB. 1997b. Definition of an element required for 1,25-dihydroxyvitamin D-Dependent Transactivation of the rat osteocalcin gene. J. Bone Miner Res 1997, 12, S1:F204.
25. Suen C, Chin WW. 1995. A potential transcriptional adaptor(s) may be required in thyroid hormone-stimulated gene transcription in vitro. Endocrinology 136:2776-2783.
26. Woods DB, Ghysdeal J, Owen MJ. 1992. Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein. Nucleic Acids Res 20:699-704.
27. Woodward RN, Li M, Holland LJ. 1997. Novel accessory factor-binding site required for glucocorticoid regulation of the gamma-fibrinogen gene from Xenopus laevis. Mol Endocrin 11:563-576.